Pharmacokinetic/Pharmacodynamic Considerations of Alternate Dosing Strategies of Tocilizumab in COVID-19

Tocilizumab is one of few treatments that have been shown to improve mortality in patients with coronavirus disease 2019 (COVID-19), but increased demand has led to relative global shortages. Recently, it has been suggested that lower doses, or fixed doses, of tocilizumab could be a potential soluti...

Descripción completa

Detalles Bibliográficos
Autores principales: Leung, Elizabeth, Crass, Ryan L., Jorgensen, Sarah C. J., Raybardhan, Sumit, Langford, Bradley J., Moore, W. Justin, Rhodes, Nathaniel J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8665708/
https://www.ncbi.nlm.nih.gov/pubmed/34894345
http://dx.doi.org/10.1007/s40262-021-01092-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8665708/
https://www.ncbi.nlm.nih.gov/pubmed/34894345
http://dx.doi.org/10.1007/s40262-021-01092-0

Ejemplares similares